Age group (in Years) | |||||
40 - 64 (%) | 65 - 74 (%) | ³75 (%) | p value | ||
Surgery |
|
|
| ||
Stage 1 (n) | 179 | 31 | 19 |
| |
Mastectomy | 115 (64.2) | 27 (87.1) | 17 (89.5) | 0.013 | |
Conservation | 63 (35.2) | 4 (12.9) | 2 (10.5) | ||
None | 1 (0.6) | 0 (0.0) | 0 (0.0) | ||
Stage 2 (n) | 298 | 75 | 40 |
| |
Mastectomy | 242 (81.2) | 70 (93.3) | 35 (87.5) | 0.007 | |
Conservation | 55 (18.5) | 4 (5.3) | 4 (10.0) | ||
None | 1 (0.3) | 1 (1.3) | 1 (2.5) | ||
Stage 3 (n) | 124 | 27 | 19 |
| |
Mastectomy | 113 (91.1) | 25 (92.6) | 16 (84.2) | 0.029 | |
Conservation | 10 (8.1) | 0 (0.0) | 1 (5.3) | ||
None | 1 (0.8) | 2 (7.4) | 2 (10.5) | ||
Stage 4# (n) | 41 | 14 | 24 | 1 | |
Mastectomy | 26 (63.4) | 10 (71.4) | 8 (33.3) | 0.050 | |
Conservation | 2 (4.9) | 1 (7.1) | 1 (4.2) | ||
None | 13 (31.7) | 3 (21.4) | 15 (62.5) | ||
Breast reconstruction^ | 40 (6.3) | 1 (0.7) | 0 (0.0) | <0.001 | |
Adjuvant Therapy* | |||||
Stage 1 | |||||
Adjuvant | 135 (77.1) | 19 (65.5) | 10 (55.6) | 0.079 | |
Chemotherapy | 49 (28.8) | 1 (3.4) | 0 (0.0) | <0.001 | |
Radiotherapy | 62 (36.5) | 4 (13.8) | 1 (5.6) | 0.002 | |
Hormone | 95 (55.6) | 18 (62.1) | 10 (55.6) | 0.804 | |
Stage 2 | |||||
Adjuvant | 262 (91.3) | 61 (87.1) | 22 (59.5) | <0.001 | |
Chemotherapy | 197 (68.6) | 15 (21.7) | 1 (2.7) | <0.001 | |
Radiotherapy | 100 (35.3) | 11 (15.9) | 5 (13.5) | <0.001 | |
Hormone | 174 (61.5) | 55 (78.6) | 23 (62.2) | 0.024 | |
Stage 3 |
|
|
|
| |
Adjuvant | 102 (90.3) | 25 (96.2) | 10 (66.7) | 0.015 | |
Chemotherapy | 98 (86.7) | 14 (60.9) | 1 (6.7) | <0.001 | |
Radiotherapy | 94 (83.9) | 19 (79.2) | 2 (13.3) | <0.001 | |
Hormone | 65 (59.1) | 18 (75.0) | 9 (60.0) | 0.377 | |
Stage 4# |
|
|
|
| |
Palliative |
|
|
|
| |
Chemotherapy | 17 (50.0) | 0 (0.0) | 0 (0.0) | <0.001 | |
Radiotherapy | 12 (37.5) | 2 (15.4) | 5 (21.7) | 0.292 | |
Hormone | 22 (64.7) | 7 (53.8) | 16 (69.6) | 0.643 | |